| Literature DB >> 18761031 |
João Luiz Quagliotti Durigan1, Sabrina Messa Peviani, Thiago Luiz Russo, Gabriel Borges Delfino, Juliana Uema Ribeiro, Márcia Regina Cominetti, Heloisa Sobreiro Selistre-de-Araujo, Tania Fátima Salvini.
Abstract
This study evaluated the effects of alternagin-C (ALT-C) on mRNA levels of VEGF, MyoD and matrix metalloproteinase 2 (MMP-2) and on activity of MMPs in injured tibialis anterior (TA) muscle induced by cryolesioning in rats. Thirty-six Wistar rats (3 months old, 258.9+/-27 g) were divided into five groups: (1) control group; (2) injured TA and analyzed 3 days later; (3) injured TA treated with ALT-C and analyzed 3 days later; (4) injured TA and analyzed 7 days later and (5) injured TA treated with ALT-C and analyzed 7 days later. The injured muscle received 25 microl of ALT-C (50 nM). The injured and uninjured muscle areas were quantified by light microscopy. The MMP activity was evaluated through zymography, and mRNA of MyoD, VEGF and MMP-2 was assessed by quantitative polymerase chain reaction. ALT-C neither reduced the muscle injury area nor altered the pattern of MyoD and VEGF expression in injured muscles. However, ALT-C reduces both MMP-2 mRNA and gelatinolytic activity in injured muscles. The study indicates that ALT-C, at the tested concentrations, did not improve muscle regeneration process in rats. The effect on MMP-2 mRNA and gelatinolytic activity suggests that ALT-C changes the overall balance of ECM protein turnover during muscle regeneration.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18761031 DOI: 10.1016/j.toxicon.2008.07.018
Source DB: PubMed Journal: Toxicon ISSN: 0041-0101 Impact factor: 3.033